Orchard Software Inks Deal with Memorial Sloan Kettering Cancer Center

| February 13, 2014


Orchard Software has entered into a long-term agreement with Memorial Sloan Kettering Cancer Center to provide state-of-the-art LIS technology and to benefit from Memorial Sloan Kettering’s expertise in superior patient care. This partnership provides Orchard with a unique opportunity to collaboratively and progressively continue development of its laboratory informatics products to strengthen and support the future of healthcare.

Orchard Software is privileged and excited to have the opportunity to partner with such a prestigious facility as Memorial Sloan Kettering Cancer Center. And, as a leading LIS in the oncology market, Orchard looks forward to being involved in the success of Memorial Sloan Kettering’s goal to provide the most advanced cancer treatments available. Orchard is eager to begin working with Memorial Sloan Kettering Cancer Center in their conquest against cancer by providing laboratory informatics to aid in the potential development of new and more effective ways to diagnose and treat disease. 

Orchard’s goal is to provide state-of the art LIS technology for the ever-changing healthcare arena—providing the flexibility, decision support, business intelligence, and analytics necessary to sustain and foster improvements in a rapidly changing healthcare environment. Working in conjunction with Memorial Sloan Kettering Cancer Center, Orchard believes the collaborative endeavor will enhance and broaden the development of our LIS products and simultaneously support Memorial Sloan Kettering’s objective to provide superior individualized diagnostic treatments for patients based on the most current evidence.

Source: Orchard Software

Tags: , ,

Category: Anatomic Pathology, Business, Clinical Laboratories, Clinical Pathology, Electronic Medical Records, General Healthcare News, Histology, Informatics, Laboratory Informatics, Laboratory Information Systems, Marketing, Medical Research, Pathology News, Vendor products

Comments are closed.